$21.115
-0.579 (-2.74%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
DMRA 相似图表分析预测
Alphio's DMRA stock price prediction model matches the current Damora Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $21.36 (+1.18%). The 1-week path is $21.60 (+2.31%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 Damora Therapeutics Inc 股票吗?
Damora Therapeutics (DMRA) is not a good buy right now, as the current price is $18.44, which is significantly below the analyst price targets of $50 and $60. However, the stock has a low RSI of 28.91, indicating it is oversold, which could present a buying opportunity in the future. The main risk is the company's substantial net losses, with a reported net income loss of $31.17 million in Q2 2026, which raises concerns about its financial health.
DMRA 股价于 Friday 收于 $21.12,此前下跌 -2.74%
Damora Therapeutics Inc (DMRA) last closed at $21.115, losing -2.74%. These facts feed the 1-day and 1-week DMRA price prediction above.
预测驱动因素
Damora Therapeutics Inc(DMRA)的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
相似图表形态
近期走势与 DMRA 最接近的股票,按相似度排序。
DMRA 季节性分析
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。